The AADAPT Act amends the Public Health Service Act to reauthorize the Project ECHO grant program and adds a new grant stream specifically to develop, evaluate, and expand technology-enabled collaborative learning for Alzheimer’s disease and related dementias. It directs HHS to award grants to public or nonprofit entities that can lead Project ECHO–style models aimed at improving primary care clinicians' ability to diagnose dementia early, deliver higher-quality dementia care, and retain providers in underserved settings.
The measure builds evaluation and reporting into the grant structure (applications must include plans to assess effects on patient outcomes and provider retention, and grantees must report to the federal Advisory Council on Alzheimer’s Research, Care, and Services). Funding for the dementia-focused grants is small and delayed relative to the reauthorized baseline program: $1 million per year authorized for fiscal years 2027–2032, layered on top of continuing Project ECHO authorizations.
At a Glance
What It Does
Creates a new category of Project ECHO grants targeted to Alzheimer’s disease and related dementias and requires HHS to award grants within one year to eligible public or nonprofit leaders of tech-enabled collaborative learning networks. Grants must support evaluation, development, and expansion of these models for frontline primary care clinicians.
Who It Affects
Primary care clinicians serving rural, frontier, HPSA, or other medically underserved areas and populations (including Native American communities); public and nonprofit organizations that run or can scale Project ECHO–style programs; and HHS divisions that will administer grants and aggregate results for federal advisory reporting.
Why It Matters
It repackages the Project ECHO model as a targeted workforce-development tool for dementia care, coupling federal funding with evaluation and federal advisory oversight. For health systems and payers, it signals a federal preference for tech-enabled, hub-and-spoke training to expand dementia expertise outside specialty centers.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill inserts a new, dementia-focused grant stream into the existing Project ECHO authority in the Public Health Service Act. It distinguishes two classes of eligible entities: the original class (entities serving rural, frontier, shortage, or medically underserved areas or Native populations) and a new class for dementia grants—public or nonprofit organizations that can lead Project ECHO–style collaboratives focused on Alzheimer’s disease and related dementias.
HHS must award one or more dementia grants within 12 months of the law’s enactment. Those grants are explicitly authorized to evaluate, develop, and expand the use of technology-enabled collaborative learning for eligible health care professionals—defined narrowly as primary care clinicians who practice in underserved settings or serve underserved populations, including Native Americans.
The aim is twofold: increase early and accurate dementia diagnosis and improve quality of dementia care while supporting provider retention in strained areas.Applicants must include plans to measure effects on both patient outcomes and health care providers. For dementia grants, recipients must also certify that federal dollars will supplement—not supplant—other funding.
Grantees will submit collected data to the federal Advisory Council on Alzheimer’s Research, Care, and Services, and HHS must produce an updated report to Congress and post it publicly within four years of the dementia-grant authorization.On money, the bill keeps the longstanding Project ECHO authorization at $10 million annually (for the previously authorized grant types through FY2022–2032) and adds a separate authorization of $1 million per year for dementia-focused grants for FY2027–2032. That funding profile creates a modest, time-shifted pool to pilot and study the approach rather than a large-scale immediate rollout.
The Five Things You Need to Know
HHS must award one or more Alzheimer’s/dementia Project ECHO grants within one year of enactment to public or nonprofit entities capable of leading tech-enabled collaboratives.
The bill defines eligible health care professionals for dementia grants as primary care clinicians practicing in rural, frontier, HPSAs, medically underserved areas, or serving medically underserved populations or Native Americans.
Applications for grants must include plans to assess effects on patient outcomes and on health care provider retention and performance.
Grantees awarded dementia grants must submit their collected information to the Advisory Council on Alzheimer’s Research, Care, and Services; HHS must publish an updated report to Congress and online within four years.
Congress authorized $1,000,000 per year for the dementia-focused Project ECHO grants for fiscal years 2027 through 2032 (separate from the $10,000,000 annual authorization for other Project ECHO grants).
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title — AADAPT Act
Provides the Act’s name: Accelerating Access to Dementia and Alzheimer’s Provider Training Act (AADAPT Act). This is the standard statutory caption and has no programmatic effect, but it signals Congress’s intent to frame the changes as workforce and access-focused.
Separates eligible-entity standards for general Project ECHO and dementia grants
Rewrites the eligible-entity definition to create two buckets: (A) the original eligibility for grants under subsection (b)(1) focused on entities serving rural/underserved areas and populations (including Tribal organizations), and (B) a new category for subsection (b)(2) that covers public or nonprofit private entities that are leading—or can lead—Project ECHO‑style dementia collaboratives. Practically this lowers the barrier for nonprofits and public entities that may not directly provide clinical services but can coordinate training networks.
Creates a targeted grant stream to develop and expand Project ECHO models for dementia care
Adds subsection (b)(2) requiring HHS to award grants within one year to evaluate, develop, and expand tech-enabled collaborative learning models specifically to support primary care clinicians in dementia diagnosis, care quality, and workforce retention. The provision explicitly ties the grant purpose to evaluation and expansion (not only dissemination), which opens the door to pilot projects, program refinement, and research on implementation strategies.
Evaluation plans and supplement‑not‑supplant assurance
Requires applicants to include plans for measuring how the collaborative learning model affects patient outcomes and providers. For dementia grants, applicants must also assure HHS that awarded funds will supplement, not replace, other funding sources. That language creates an accountability expectation but leaves enforcement and interpretation to HHS rulemaking or grant conditions.
Grantee reporting to federal Advisory Council, HHS updates, and small dedicated funding
Mandates that dementia-grant recipients report collected information to the Advisory Council on Alzheimer’s Research, Care, and Services. It requires HHS to post an updated report to Congress and online within four years of the dementia-grant authorization. The bill also authorizes $1 million per year for the dementia grants for FY2027–2032 and maintains a $10 million annual authorization for other Project ECHO grants through 2032—establishing a limited, time-bound funding stream for dementia-focused activities.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Primary care clinicians in rural and medically underserved areas — they gain structured, ongoing remote access to dementia expertise, which can improve confidence in diagnosing and managing dementia without immediate referral to specialists.
- Patients in underserved and Native American communities — expanded provider capacity and earlier diagnosis can increase access to care pathways and support services that were previously limited to specialty clinics.
- Public and nonprofit organizations that run or can scale Project ECHO programs — they become eligible for targeted federal grants to expand dementia-focused training and evaluation work.
- The Advisory Council on Alzheimer’s Research, Care, and Services and policymakers — they receive new, grantee-generated data to inform federal strategy on workforce development and dementia care.
Who Bears the Cost
- Department of Health and Human Services — must administer the new grant stream, review applications, monitor evaluations, coordinate reporting to Congress, and publish updates, creating administrative workload and requiring appropriation execution.
- Grantee organizations — must design and run evaluations, collect and report data to the Advisory Council, and comply with supplement‑not‑supplant assurances, imposing operational and measurement costs.
- Primary care practices participating in ECHO networks — will allocate clinician time for case learning and training sessions, an implicit cost in lost billable time unless supported by their organizations or payers.
- Congressional appropriations — the $1 million annual authorization for dementia grants will compete with other budget priorities; appropriators must decide whether to fund the modest earmark starting in FY2027.
Key Issues
The Core Tension
The bill balances a demand for evidence and accountability (evaluation plans, reporting to a federal advisory council) against the need to rapidly expand frontline dementia capacity; it funds pilots and measurement but not a large, immediate scale-up—so policymakers must choose between careful learning with modest investment or pushing for broader, underfunded deployment that risks poor implementation and unclear outcomes.
Two practical constraints stand out. First, the dementia grant authorization is modest ($1M/year for FY2027–2032) and delayed (authorization begins in 2027), so the bill is designed as a pilot/learning investment rather than a large-scale scale-up.
That raises questions about geographic coverage, pace of expansion, and whether $1 million annually can support multiple meaningful hubs, robust evaluations, and sustained clinician engagement. Second, the statute requires evaluations and reports but does not prescribe standardized metrics, data-sharing protocols, or specific evaluation designs.
HHS and grantees will need to reconcile variation in electronic health record access, small-sample statistics in rural areas, and privacy constraints when demonstrating effects on diagnosis accuracy, patient outcomes, and provider retention.
There is also operational friction around the supplement‑not‑supplant assurance: it prevents federal funds from displacing existing resources, but the statute doesn't define how HHS will verify compliance. Small public and nonprofit entities may struggle to document baseline funding streams, particularly when program dollars mix with state, philanthropic, or health system contributions.
Finally, while the bill explicitly includes Native American populations and Tribal organizations in eligibility language, meaningful cultural adaptation and Tribal sovereignty considerations will require consultation and potentially additional resources not allocated in the authorization.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.